FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma

Radiology

Volumn 260, Issue 2, 2011, Pages 503-510

  Bernstine, Hanna ^a,b   Braun, Marius ^a,b   Yefremov, Nikolay ^a   Lamash, Yechiel ^c,d   Carmi, Raz ^c   Stern, Dorit ^a,e   Steinmetz, Adam ^a   Sosna, Jacob ^f,g   Groshar, David ^a,b,e  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c PHILIPS HEALTHCARE   (United States)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e ASSUTA MEDICAL CENTER   (Israel)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; CANCER INVASION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; LIVER CELL CARCINOMA; LIVER PERFUSION; MALE; METABOLISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARDIZATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TUMOR CLASSIFICATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROC CURVE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960664504     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11102350     Document Type: Article

References (25)

1. Thomas MB, Jaffe D, Choti MM, et al. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute clinical trials planning meeting. J Clin Oncol 2010;28(25):3994-4005.
2. Ippolito D, Sironi S, Pozzi M, et al. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. Eur J Radiol 2010;73(1):148-152.
3. Zhong L, Wang W-J, Xu J-R. Clinical application of hepatic CT perfusion. World J Gastroenterol 2009;15(8):907-911.
4. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234(3):661-673. (Pubitemid 40250807)
5. Ippolito D, Sironi S, Pozzi M, et al. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations. J Comput Assist Tomogr 2008;32(6):855-858.
6. Thng CH, Koh TS, Collins DJ, Koh DM. Perfusion magnetic resonance imaging of the liver. World J Gastroenterol 2010;16(13):1598-1609.
7. Veit-Haibach P, Treyer V, Strobel K, et al. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging 2010; 35(5):528-536.
8. Ippolito D, Sironi S, Pozzi M, et al. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 2008;15(7):919-927. (Pubitemid 352033551)
9. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - initial experience. Radiology 2007;243(3):736-743. (Pubitemid 46799427)
10. Delbeke D, Pinson CW. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 2003;44(2):222-223.
11. Ho CL, Yu SCH, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003; 44(2):213-221.
12. Lee JD, Yang WI, Park YN, et al. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased(18)F-FDG uptake. J Nucl Med 2005;46(10):1753-1759. (Pubitemid 46211600)
13. Brix G, Ziegler SI, Bellemann ME, et al. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med 2001;42(8):1265-1273.
14. Wudel LJ Jr, Delbeke D, Morris D, et al. The role of [18F] fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 2003;69(2):117-124; discussion 124-126.
15. Mullani NA, Herbst RS, O'Neil RG, Gould KL, Barron BJ, Abbruzzese JL. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow. J Nucl Med 2008;49(4):517-523. (Pubitemid 351520598)
16. Mullani NA, Ekas RD, Marani S, Kim EE, Gould KL. Feasibility of measuring first pass extraction and flow with rubidium-82 in the kidneys. Am J Physiol Imaging 1990;5(4):133-140.
17. Mullani NA, Gould KL. First-pass measurements of regional blood flow with external detectors. J Nucl Med 1983;24(7):577-581. (Pubitemid 13049707)
18. Mullani NA, Goldstein RA, Gould KL, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983;24(10):898-906.
19. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996; 37(10):1701-1712. (Pubitemid 26337184)
20. Davenport R. The derivation of the gamma-variate relationship for tracer dilution curves. J Nucl Med 1983;24(10):945-948. (Pubitemid 14236778)
21. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993;188(2):405-411. (Pubitemid 23216260)
22. Sarper R, Fajman WA, Rypins EB, et al. A noninvasive method for measuring portal venous/total hepatic blood flow by hepatosplenic radionuclide angiography. Radiology 1981;141(1):179-184. (Pubitemid 11006932)
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-845.
24. Yamaguchi R, Yano H, Nakashima O, et al. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol 2006;21(1 Pt 1):152-160.
25. Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33(1):22-28. (Pubitemid 41785305)